complement cystic fibrosis quantitative functional assessment made classical alternative pathway complement activation serum 23 patient cystic fibrosis classical pathway functioned similarly patient control measured ch50 titre alternative pathway function initiated patient serum incubation inulin equal control determined cleavage factor b c3 consumption terminal component factor b however readily activated patient control serum rapid alteration factor b lead accelerated extensive activation terminal complement component via alternative pathway assessed c3 cleavage consumption terminal component thus complement deficiency found importance easily activated factor b undefined